Header

UZH-Logo

Maintenance Infos

Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder


Uehleke, B; Schaper, S; Dienel, A; Schlaefke, S; Stange, R (2012). Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder. Phytomedicine, 19(8-9):665-671.

Statistics

Citations

Dimensions.ai Metrics
14 citations in Web of Science®
25 citations in Scopus®
21 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 16 Nov 2012
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Complementary Medicine
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Life Sciences > Molecular Medicine
Life Sciences > Pharmacology
Life Sciences > Pharmaceutical Science
Life Sciences > Drug Discovery
Health Sciences > Complementary and Alternative Medicine
Language:English
Date:2012
Deposited On:16 Nov 2012 15:49
Last Modified:11 Mar 2020 23:55
Publisher:Elsevier
ISSN:0944-7113
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1016/j.phymed.2012.02.020

Download

Closed Access: Download allowed only for UZH members